Health care stocks declined Thursday afternoon with the NYSE Health Care Index falling 2.2% and the Health Care Select Sector SPDR Fund (XLV) down 2.2%.
The iShares Biotechnology ETF (IBB) shed 1.3%.
In corporate news, Eli Lilly (LLY) slashed its full-year earnings outlook due to acquisition-related charges, while Q1 results surpassed market expectations. The shares slumped 10%.
Moderna's (MRNA) Q1 loss unexpectedly narrowed as a drop in expenses helped counter the decline in revenue. The stock fell 4.8%.
CVS Health (CVS) raised its full-year earnings outlook after reporting stronger-than-expected Q1 results. The shares jumped 6.3%.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。